![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessA phase 2 study of carfilzomib, cyclophosphamide and dexamethasone as frontline treatment for transplant-eligible MM with high-risk features (SGH-MM1)
-
Article
Open AccessHigh-dose methotrexate is effective for prevention of isolated CNS relapse in diffuse large B cell lymphoma
The role of central nervous system (CNS) prophylaxis with high-dose methotrexate (HDMTX) in DLBCL is controversial. In this retrospective study, we evaluated the efficacy of prophylactic HDMTX on isolated CNS ...
-
Article
Risk factors and predictors of treatment responses and complications in immune thrombocytopenia
Management of adult patients with immune thrombocytopenia (ITP) is often unsatisfactory, due to variable efficacy of treatment, risk of life-threatening bleeding if disease control is poor, and side effects as...
-
Article
Howell–Jolly bodies in systemic amyloidosis
-
Article
Marked hypereosinophilia and rash as initial presentation of acute myeloid leukemia with t(8;21)
-
Article
Rivaroxaban for heparin-induced thrombocytopenia: adding to the evidence
-
Article
Open AccessUse of Valacyclovir for the treatment of cytomegalovirus antigenemia after hematopoietic stem cell transplantation
Valacyclovir has been used for prophylaxis against cytomegalovirus (CMV) infection after hematopoietic stem cell transplantation (HSCT). We investigated the efficacy and safety of high-dose Valacyclovir as pre...